Stage IB lung adenocarcinoma: thoracoscopic lobectomy with anomalous pulmonary vein anatomy

Patient Info: Anonymized, Female, 50s | Stage I

Stage IB lung adenocarcinoma was treated with thoracoscopic left lower lobectomy and lymph-node dissection; she recovered uneventfully and was discharged on postoperative day 3.

PubMed CentralRead more →

Stage I lung adenocarcinoma: no recurrence after thoracoscopic lobectomy

Patient Info: Anonymized, Male, 60s | Stage I

No recurrence at 3 months after thoracoscopic right upper lobectomy for pT1cN0M0 lung adenocarcinoma; no additional treatment was needed.

PubMed CentralRead more →

Stage I lung adenocarcinoma treated with SBRT after pacemaker relocation

Patient Info: Anonymized, Female, 70+ | Stage I

As of December 2024, CT showed complete resolution of the lung ground-glass lesion and no recurrence 4 years and 10 months after SBRT for Stage I lung adenocarcinoma, with stable pacemaker function.

PubMed CentralRead more →

Stage I lung adenocarcinoma: post-lobectomy hemothorax resolved with tPA/DNase

Patient Info: Anonymized, Female, 70+ | Stage I

Early-stage lung adenocarcinoma was surgically treated with left upper lobectomy; postoperative hemothorax resolved after chest-tube drainage, bronchoscopy, and intrapleural tPA/DNase, with no hemothorax recurrence at follow-up.

PubMed CentralRead more →

Stage III MET Exon 14-Positive Lung Adenocarcinoma Treated With Targeted Therapy Before Surgery

Patient Info: Anonymized, male, 60s | Stage I

Biomarkers: MET exon 14 skipping mutation; TP53 mutation

Postoperative pathology showed no involved lymph nodes and a lower pathologic Stage I group after treatment. No relapse was seen at the 6-month postoperative follow-up.

PubMed CentralRead more →

Stage 1 lung adenocarcinoma: no recurrence after 2 years

Patient Info: Anonymized, Female, 50s | Stage I

No recurrence or surgical complications 2 years after uniportal video-assisted thoracoscopic left middle lobectomy and left upper-lobe wedge resection for Stage IB lung adenocarcinoma in situs inversus totalis.

PubMed CentralRead more →

Stage 1 lung adenocarcinoma: NED after surgery alone

Patient Info: Anonymized, Male, 70+ | Stage I

Biomarkers: MET exon 14 skipping; PIK3CA p.; KRAS exon 2 p./D

Both independent early-stage lung adenocarcinomas were resected without lymph-node metastasis; follow-up showed normalized oncologic markers, negative lung-cancer autoantibodies, improved HRCT findings, and no recurrence for 1 year.

PubMed CentralRead more →

Stage 1 EGFR lung adenocarcinoma treated with radiotherapy

Patient Info: Anonymized, Male, 70+ | Stage I

Biomarkers: EGFR exon 19 deletion; other common drivers not detected.

Stage IB EGFR exon 19 deletion lung adenocarcinoma was treated with definitive radiotherapy because of fragile condition after spinal cord infarction; at 5 months, the lesion showed no significant change and there was no recurrence or radiation pneumonitis.

PubMed CentralRead more →

Two early-stage primary lung cancers and bronchopleural fistula closure with VV-ECMO support

Patient Info: Anonymized, Male, 50s | Stage I

As of May 2024, the postoperative bronchopleural fistula had been successfully closed, the residual cavity had closed, and no BPF was seen on 3-month CT; longer cancer recurrence surveillance was not reported.

PubMed CentralRead more →

Stage I EGFR Lung Adenocarcinoma: Phuong's Survivor Story

Patient Info: Phuong Ho, Female | Stage I

Biomarkers: EGFR alteration

Phuong has been cancer-free for 3 years and continues working on her lung capacity and overall fitness.

Stage I lung adenocarcinoma diagnosed alongside follicular lymphoma

Patient Info: Anonymized, male, 60s | Stage I

A 69-year-old man was found to have Stage I lung adenocarcinoma and a separate follicular lymphoma, allowing each cancer to be managed independently.

PubMed CentralRead more →

Stage I papillary lung adenocarcinoma treated with robotic segmentectomy despite an abnormal pulmonary vein

Patient Info: Anonymized, male, 70+ | Stage I

One year after surgery, there was no lung-cancer recurrence and no respiratory or right-sided heart-failure symptoms.

PubMed CentralRead more →

Stage I Lung Cancer: Lauren's Patient Story

Patient Info: Lauren Koy, Female, Under 40 | Stage I

Biomarkers: CD56-positive neuroendocrine tumor; no gene mutations reported

As of January 2024, Lauren’s diagnosis had been established and bronchoscopy had reopened the blocked right-lung airway; later definitive treatment or long-term status was not described in this record.

The Patient StoryRead more →

Stage I lung squamous cell carcinoma: surgery and IMRT for localized tracheal recurrence

Patient Info: Anonymized, Male, 60s | Stage I

Three months after IMRT, PET-CT and bronchoscopy showed no residual tracheal lesion, no mediastinal lymph-node involvement, and no metastasis; he remained alive in the third year of follow-up with 6-month monitoring.

PubMed CentralRead more →

Two synchronous Stage I squamous lung cancers treated with lobectomy

Patient Info: Anonymized, male, 70+ | Stage I

At 5 months after surgery, his overall condition remained good.

PubMed CentralRead more →

Stage I Lung Cancer: Debra's Survivor Story

Patient Info: Debra Haberstroh, Female | Stage I

As of November 2023, Debra was 5 months after May 2023 lung tumor resection, did not need chemotherapy, was described by her oncologist as technically cured, and continued surveillance imaging.

Cleveland ClinicRead more →

Stage I Lung Cancer: Lauren's Survivor Story

Patient Info: Lauren, Female, Under 40 | Stage I

Biomarkers: CD56-positive; neuroendocrine tumor

As of August 2023, Lauren reported no signs of more cancer after bronchoscopy and surgery removing the right lower and middle lung lobes, with surveillance extended to yearly CT scans.

The Patient StoryRead more →

My Lung Cancer Symptoms: "They Thought it was Asthma!" (Lauren’s Story)

Patient Info: Lauren Koy, Female, Under 40 | Stage I

Biomarkers: No genetic factors reported

As of August 2023, Lauren described lung cancer diagnosis after years of symptoms and surgery to remove part of her lung, then used her story to advocate for being heard despite young age and no smoking history.

The Patient StoryRead more →

Stage I Lung Cancer: Terri's Survivor Story

Patient Info: Terri Ann DiJulio, Female, 40s | Stage I

Biomarkers: Not reported for patient; family history of lung cancer noted

As of June 2023, Terri Ann was considered no evidence of disease after 3 early-stage lung cancer diagnoses treated with surgery and SBRT, and she had returned to 6-month follow-up while continuing advocacy and cycling.

The Patient StoryRead more →

Rare lung sarcoma causing repeated collapsed lungs

Patient Info: Anonymized, Female | Stage I

Biomarkers: SS18-SSX2 fusion; CD99-positive; epithelial membrane antigen-positive; TLE1-positive; BCL-2-positive

She remained well under surveillance, with no evidence of disease on imaging at 3 years after definitive lobectomy.

PubMed CentralRead more →

Stage I Lung Cancer: Dave's Survivor Story

Patient Info: Dave Bjork, Male | Stage I

As of November 2021, Dave was a Stage I lung cancer survivor after surgery-only treatment, with no chemotherapy reported, and was active in lung cancer awareness advocacy.

The Patient StoryRead more →

Stage I Lung Cancer: Bonnie's Survivor Story

Patient Info: Bonnie Ulrich, Female | Stage I

As of November 2021, Bonnie was described as in remission after Stage I lung cancer treated with surgery only, and as a 3-time lung cancer survivor active in anti-stigma advocacy.

The Patient StoryRead more →

Stage I EGFR Lung Adenocarcinoma: Ashley's Patient Story

Patient Info: Ashley Stringer, Female, Under 40 | Stage I

Biomarkers: EGFR-positive

As of May 2021, Ashley was 4 years from diagnosis after lobectomy and 2 radiation courses, with ongoing monitoring of lung nodules and possible future EGFR-targeted therapy if needed.

MD AndersonRead more →

A small primary lung adenocarcinoma found during treatment for a separate gestational cancer

Patient Info: Anonymized, Female, 50s | Stage I

Biomarkers: TTF-1 positive; napsin A positive.

The 9 mm lung adenocarcinoma was removed with clear margins and described as curatively resected, with CT surveillance continuing every six months.

PubMed CentralRead more →